Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies

BACKGROUND: The phosphoinositide 3-kinase (PI3K)/Akt pathway is constitutively activated in pancreatic cancer and the mammalian target of rapamycin (mTOR) kinase is an important mediator for its signaling. Our recent in vitro studies suggest that prolonged exposure of pancreatic cancer cells to mTOR...

Descripción completa

Detalles Bibliográficos
Autores principales: Javle, Milind M, Shroff, Rachna T, Xiong, Henry, Varadhachary, Gauri A, Fogelman, David, Reddy, Shrikanth A, Davis, Darren, Zhang, Yujian, Wolff, Robert A, Abbruzzese, James L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910694/
https://www.ncbi.nlm.nih.gov/pubmed/20630061
http://dx.doi.org/10.1186/1471-2407-10-368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910694/
https://www.ncbi.nlm.nih.gov/pubmed/20630061
http://dx.doi.org/10.1186/1471-2407-10-368

Ejemplares similares